Wikidata |

Wikidata

Matches in Wikidata for { <http://www.wikidata.org/entity/Q37302739> ?p ?o ?g. }

Showing items 1 to 100 of ±157 with 100 items per page.

Q37302739 description "article científic" @default.
Q37302739 description "article scientifique" @default.
Q37302739 description "articolo scientifico" @default.
Q37302739 description "artigo científico" @default.
Q37302739 description "artículu científicu espublizáu en 2016" @default.
Q37302739 description "bilimsel makale" @default.
Q37302739 description "research work" @default.
Q37302739 description "vedecký článok" @default.
Q37302739 description "vetenskaplig artikel" @default.
Q37302739 description "videnskabelig artikel" @default.
Q37302739 description "vědecký článek" @default.
Q37302739 description "wetenschappelijk artikel" @default.
Q37302739 description "wissenschaftlicher Artikel" @default.
Q37302739 description "наукова стаття, опублікована у вересні 2016" @default.
Q37302739 description "научни чланак" @default.
Q37302739 description "مقالة علمية نشرت في 15 سبتمبر 2016" @default.
Q37302739 name "Association Between the Occurrence of Adverse Drug Events and Modification of First-Line Highly Active Antiretroviral Therapy in Ghanaian HIV Patients" @default.
Q37302739 name "Association Between the Occurrence of Adverse Drug Events and Modification of First-Line Highly Active Antiretroviral Therapy in Ghanaian HIV Patients." @default.
Q37302739 name "Association Between the Occurrence of Adverse Drug Events and Modification of First-Line Highly Active Antiretroviral Therapy in Ghanaian HIV Patients." @default.
Q37302739 type Item @default.
Q37302739 label "Association Between the Occurrence of Adverse Drug Events and Modification of First-Line Highly Active Antiretroviral Therapy in Ghanaian HIV Patients" @default.
Q37302739 label "Association Between the Occurrence of Adverse Drug Events and Modification of First-Line Highly Active Antiretroviral Therapy in Ghanaian HIV Patients." @default.
Q37302739 label "Association Between the Occurrence of Adverse Drug Events and Modification of First-Line Highly Active Antiretroviral Therapy in Ghanaian HIV Patients." @default.
Q37302739 prefLabel "Association Between the Occurrence of Adverse Drug Events and Modification of First-Line Highly Active Antiretroviral Therapy in Ghanaian HIV Patients" @default.
Q37302739 prefLabel "Association Between the Occurrence of Adverse Drug Events and Modification of First-Line Highly Active Antiretroviral Therapy in Ghanaian HIV Patients." @default.
Q37302739 prefLabel "Association Between the Occurrence of Adverse Drug Events and Modification of First-Line Highly Active Antiretroviral Therapy in Ghanaian HIV Patients." @default.
Q37302739 P1433 Q37302739-75073F19-A873-4E78-8B3D-8FE76FB76168 @default.
Q37302739 P1476 Q37302739-F0136362-6A18-4CFA-A854-4CDC91BF1363 @default.
Q37302739 P2093 Q37302739-21BACDDE-0424-41CE-8B40-958064177DD2 @default.
Q37302739 P2093 Q37302739-277B9D33-2453-4B1A-BAF9-48637FB72FEC @default.
Q37302739 P2093 Q37302739-3EF96276-55A3-4CE9-9310-A253E79107D1 @default.
Q37302739 P2093 Q37302739-4B6C447C-89B6-4031-BB15-C80AC4E90953 @default.
Q37302739 P2093 Q37302739-5DC59F22-AD7F-4933-BD03-D419FE3EAFD3 @default.
Q37302739 P2093 Q37302739-61B8F3BE-710A-4A87-A848-7D09F9BF920E @default.
Q37302739 P2093 Q37302739-7A2E6137-4159-4574-8016-B37CC1952473 @default.
Q37302739 P2093 Q37302739-7C06F669-95BF-47D0-B056-B51BB6135855 @default.
Q37302739 P2093 Q37302739-B63A300D-BF84-4C36-87AD-D33E58015998 @default.
Q37302739 P2093 Q37302739-D0D81952-3DB1-4257-89EC-4AD2F74443A6 @default.
Q37302739 P2093 Q37302739-DDE6E11C-3EEB-4EEE-B1F1-F27D8A15E4E2 @default.
Q37302739 P275 Q37302739-fc3cde63-897a-4d41-9715-e8f4ef5b995f @default.
Q37302739 P2860 Q37302739-02E36010-05F9-4B86-BD34-59C7C75125D4 @default.
Q37302739 P2860 Q37302739-036FC402-1CF2-44B1-A14C-74AAA38DFE64 @default.
Q37302739 P2860 Q37302739-04EB774A-8DFA-41E2-8068-BC63B08CFB8B @default.
Q37302739 P2860 Q37302739-0959B345-3696-47E2-ABFB-CFDFAE876BED @default.
Q37302739 P2860 Q37302739-0B03A615-2F42-41D8-8397-09DD1DDB133B @default.
Q37302739 P2860 Q37302739-0B87153A-5549-4F92-B73E-3A6803C9420E @default.
Q37302739 P2860 Q37302739-12363582-2384-4B39-8102-0309148FA270 @default.
Q37302739 P2860 Q37302739-1CEAD24F-404B-4C0F-98E2-7DBA5F15A90B @default.
Q37302739 P2860 Q37302739-2600A9BA-EC6A-47C0-8798-1105A3EE30C9 @default.
Q37302739 P2860 Q37302739-465D2B3D-03F5-416D-9AEE-1BC398EC9144 @default.
Q37302739 P2860 Q37302739-482F0037-B5C9-4538-AED8-53050C66936B @default.
Q37302739 P2860 Q37302739-51147352-385E-434D-A0D4-ED3EE302E51A @default.
Q37302739 P2860 Q37302739-599719E8-CDC5-4C65-A6D2-BC99B94C289B @default.
Q37302739 P2860 Q37302739-59F8EC93-2627-4331-AB27-08B0A08C1E43 @default.
Q37302739 P2860 Q37302739-5C0DF85D-11CB-43B2-8A1A-994F3A4198EA @default.
Q37302739 P2860 Q37302739-7001C630-93E6-441D-A11B-1733F27817BD @default.
Q37302739 P2860 Q37302739-70DF0929-BA07-4A9F-B0BF-18C9664C3E44 @default.
Q37302739 P2860 Q37302739-88E61E91-E532-4538-A5B3-A7A3EA2853ED @default.
Q37302739 P2860 Q37302739-8F381A86-D49A-4D63-B9CE-567BBE55DBF2 @default.
Q37302739 P2860 Q37302739-8FC90E29-03F8-4D60-B2E1-87FD40AF0199 @default.
Q37302739 P2860 Q37302739-9F1826CA-1495-409F-8600-48EAB6F19362 @default.
Q37302739 P2860 Q37302739-A046EAA4-DEA8-4E81-89C4-1DEFA370A3BA @default.
Q37302739 P2860 Q37302739-A377CD66-DEB0-488E-986E-C0A6C5D1B60A @default.
Q37302739 P2860 Q37302739-A86930A8-54C3-473B-8886-1015032DFAAA @default.
Q37302739 P2860 Q37302739-B19CA85A-9976-466A-B6EA-EB177A5366FF @default.
Q37302739 P2860 Q37302739-B5480910-9270-45A5-B9C6-83F2DF6FE3CD @default.
Q37302739 P2860 Q37302739-DAE11459-7C2B-4B56-A2B6-188645667C00 @default.
Q37302739 P2860 Q37302739-DB3DCF88-686F-4668-A26E-922083F6ACD2 @default.
Q37302739 P2860 Q37302739-DDC5A4FD-4F68-43C6-9D68-1CFA4112C23D @default.
Q37302739 P2860 Q37302739-EA5A7052-BDFF-49AA-853D-AFF89EB5500D @default.
Q37302739 P2860 Q37302739-F362DAFD-1A78-41FA-8408-355F1CBA243F @default.
Q37302739 P2860 Q37302739-F576D67E-D46B-4F1D-91A7-C709F2B87896 @default.
Q37302739 P2860 Q37302739-F67A0343-D92B-40CD-9C70-6D0DA707BD39 @default.
Q37302739 P2860 Q37302739-FD997420-A250-48EA-BD67-2B92075721E4 @default.
Q37302739 P2888 Q37302739-2BAC900A-2A04-4323-8926-5BAF6C60E59A @default.
Q37302739 P2888 Q37302739-C5FEB756-F4AC-4296-83A6-F50754DEF939 @default.
Q37302739 P304 Q37302739-617D454F-5CAA-491B-AED5-798106D3B6F3 @default.
Q37302739 P31 Q37302739-D8A7DC41-33DE-45F8-9CCE-3E10C98B7982 @default.
Q37302739 P356 Q37302739-D586C2A4-3057-44F5-82F1-410821651D12 @default.
Q37302739 P407 Q37302739-3AA47482-E56C-47D4-8118-7502E75057ED @default.
Q37302739 P433 Q37302739-AB48A775-30A0-40DF-A325-DEF9D861004E @default.
Q37302739 P478 Q37302739-D2DF7CE7-BBA6-478B-85E5-0BCFF0D1704C @default.
Q37302739 P50 Q37302739-48141182-0B75-4B97-A1AE-8CDA28098251 @default.
Q37302739 P50 Q37302739-B963F81A-735F-4E75-A5FB-E03DE93DFED4 @default.
Q37302739 P577 Q37302739-258333B6-270E-4A96-B703-43B96828550C @default.
Q37302739 P577 Q37302739-9EEBA789-D828-4852-904C-B044A9B245DD @default.
Q37302739 P6216 Q37302739-2b51d1e2-af46-45aa-8074-d1963d2374a2 @default.
Q37302739 P698 Q37302739-CE733B90-881F-4F78-BD70-ED2DA165C185 @default.
Q37302739 P8602 Q37302739-6C7C36B9-C454-4415-9C2B-45FBEC38E4B0 @default.
Q37302739 P921 Q37302739-6719774E-E9B3-48B9-B133-7AD98CCC0B42 @default.
Q37302739 P932 Q37302739-1DE8618D-EC16-4BF0-AAD2-F75C47745656 @default.
Q37302739 P356 S40264-016-0460-7 @default.
Q37302739 P698 27638659 @default.
Q37302739 P1433 Q15724462 @default.
Q37302739 P1476 "Association Between the Occurrence of Adverse Drug Events and Modification of First-Line Highly Active Antiretroviral Therapy in Ghanaian HIV Patients" @default.
Q37302739 P2093 "Alexander N O Dodoo" @default.
Q37302739 P2093 "Aukje K Mantel-Teeuwisse" @default.
Q37302739 P2093 "Barbara A Yankey" @default.
Q37302739 P2093 "Edmund T Nartey" @default.
Q37302739 P2093 "Hubert G M Leufkens" @default.